![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print February 18, 2005
Ohio State University, Columbus, Ohio 43210
Corresponding Author: leone-1{at}medctr.osu.edu
The E2F transcription factor family plays a crucial and well-established role in cell cycle progression. Deregulation of E2F activities in vivo leads to developmental defects and cancer. Based on current evidence in the field, mammalian E2Fs can be functionally categorized into either transcriptional activators (E2F1, E2F2 and E2F3a) or repressors (E2F3b, E2F4, E2F5, E2F6 and E2F7). We have identified a novel E2F family member, E2F8, which is conserved in mice and humans and has its counterpart in Arabidopsis thaliana (E2Ls). Interestingly, E2F7 and E2F8 share unique structural features that distinguish them from other mammalian E2F repressor members, including the presence of two distinct DNA-binding domains and the absence of DP-dimerization, Retinoblastoma-binding, and transcriptional activation domains. Like E2F7, over-expression of E2F8 significantly slows down the proliferation of primary mouse embryonic fibroblasts. These observations, together with the fact that E2F7 and E2F8 can homodimerize and are expressed in the same adult tissues, suggest that they may have overlapping and perhaps synergistic roles in the control of cellular proliferation.
J. Biol. Chem, 10.1074/jbc.M501410200
Submitted on February 7, 2005
Revised on February 18, 2005
Accepted on February 15, 2005
Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. Lammens, V. Boudolf, L. Kheibarshekan, L. Panagiotis Zalmas, T. Gaamouche, S. Maes, M. Vanstraelen, E. Kondorosi, N. B. La Thangue, W. Govaerts, et al. Atypical E2F activity restrains APC/CCCS52A2 function obligatory for endocycle onset PNAS, September 23, 2008; 105(38): 14721 - 14726. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Enos, S. A. Bancos, T. Bushnell, and I. N. Crispe E2F4 Modulates Differentiation and Gene Expression in Hematopoietic Progenitor Cells during Commitment to the Lymphoid Lineage J. Immunol., March 15, 2008; 180(6): 3699 - 3707. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Freeman, Y. Ma, and W. D. Cress RhoBTB2 (DBC2) Is a Mitotic E2F1 Target Gene with a Novel Role in Apoptosis J. Biol. Chem., January 25, 2008; 283(4): 2353 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Saenz-Robles, J. A. Markovics, J.-L. Chong, R. Opavsky, R. H. Whitehead, G. Leone, and J. M. Pipas Intestinal Hyperplasia Induced by Simian Virus 40 Large Tumor Antigen Requires E2F2 J. Virol., December 1, 2007; 81(23): 13191 - 13199. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schertel and B. Conradt C. elegans orthologs of components of the RB tumor suppressor complex have distinct pro-apoptotic functions Development, October 15, 2007; 134(20): 3691 - 3701. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Giangrande, J. Zhang, A. Tanner, A. D. Eckhart, R. E. Rempel, E. R. Andrechek, J. M. Layzer, J. R. Keys, P.-O. Hagen, J. R. Nevins, et al. Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia PNAS, August 7, 2007; 104(32): 12988 - 12993. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. McClellan, V. A. Ruzhynsky, D. N. Douda, J. L. Vanderluit, K. L. Ferguson, D. Chen, R. Bremner, D. S. Park, G. Leone, and R. S. Slack Unique Requirement for Rb/E2F3 in Neuronal Migration: Evidence for Cell Cycle-Independent Functions Mol. Cell. Biol., July 1, 2007; 27(13): 4825 - 4843. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Parisi, T. L. Yuan, A. M. Faust, A. M. Caron, R. Bronson, and J. A. Lees Selective Requirements for E2f3 in the Development and Tumorigenicity of Rb-Deficient Chimeric Tissues Mol. Cell. Biol., March 15, 2007; 27(6): 2283 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qiao, L. Di Stefano, C. Tian, Y.-Y. Li, Y.-H. Yin, X.-P. Qian, X.-W. Pang, Y. Li, M. A. McNutt, K. Helin, et al. Human TFDP3, a Novel DP Protein, Inhibits DNA Binding and Transactivation by E2F J. Biol. Chem., January 5, 2007; 282(1): 454 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Timmers, N. Sharma, R. Opavsky, B. Maiti, L. Wu, J. Wu, D. Orringer, P. Trikha, H. I. Saavedra, and G. Leone E2f1, E2f2, and E2f3 Control E2F Target Expression and Cellular Proliferation via a p53-Dependent Negative Feedback Loop Mol. Cell. Biol., January 1, 2007; 27(1): 65 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Reimer, S. Sadr, A. Wiedemair, S. Stadlmann, N. Concin, G. Hofstetter, E. Muller-Holzner, C. Marth, and A. G. Zeimet Clinical Relevance of E2F Family Members in Ovarian Cancer--An Evaluation in a Training Set of 77 Patients Clin. Cancer Res., January 1, 2007; 13(1): 144 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hayashi, Y. Goto, R. Ikeda, K. K. Yokoyama, and K. Yoshida CDCA4 Is an E2F Transcription Factor Family-induced Nuclear Factor That Regulates E2F-dependent Transcriptional Activation and Cell Proliferation J. Biol. Chem., November 24, 2006; 281(47): 35633 - 35648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. del Pozo, S. Diaz-Trivino, N. Cisneros, and C. Gutierrez The Balance between Cell Division and Endoreplication Depends on E2FC-DPB, Transcription Factors Regulated by the Ubiquitin-SCFSKP2A Pathway in Arabidopsis PLANT CELL, September 1, 2006; 18(9): 2224 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Rodriguez, M. A. Glozak, Y. Ma, and W. D. Cress Bok, Bcl-2-related Ovarian Killer, Is Cell Cycle-regulated and Sensitizes to Stress-induced Apoptosis J. Biol. Chem., August 11, 2006; 281(32): 22729 - 22735. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Kinross, A. J. Clark, R. M. Iazzolino, and P. O. Humbert E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation Blood, August 1, 2006; 108(3): 886 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Louie, A. S. Revenko, J. X. Zou, J. Yao, and H.-W. Chen Direct Control of Cell Cycle Gene Expression by Proto-Oncogene Product ACTR, and Its Autoregulation Underlies Its Transforming Activity Mol. Cell. Biol., May 15, 2006; 26(10): 3810 - 3823. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. I. Rasheva, D. Knight, P. Bozko, K. Marsh, and M. V. Frolov Specific Role of the SR Protein Splicing Factor B52 in Cell Cycle Control in Drosophila. Mol. Cell. Biol., May 1, 2006; 26(9): 3468 - 3477. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sozzani, C. Maggio, S. Varotto, S. Canova, C. Bergounioux, D. Albani, and R. Cella Interplay between Arabidopsis Activating Factors E2Fb and E2Fa in Cell Cycle Progression and Development Plant Physiology, April 1, 2006; 140(4): 1355 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Conti and G. C. Hunter Gene Therapy and Vein Graft Patency in Coronary Artery Bypass Graft Surgery JAMA, November 16, 2005; 294(19): 2495 - 2497. [Full Text] [PDF] |
||||
![]() |
PREVENT IV Investigators Efficacy and Safety of Edifoligide, an E2F Transcription Factor Decoy, for Prevention of Vein Graft Failure Following Coronary Artery Bypass Graft Surgery: PREVENT IV: A Randomized Controlled Trial JAMA, November 16, 2005; 294(19): 2446 - 2454. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Verlinden, G. Eelen, I. Beullens, M. Van Camp, P. Van Hummelen, K. Engelen, R. Van Hellemont, K. Marchal, B. De Moor, F. Foijer, et al. Characterization of the Condensin Component Cnap1 and Protein Kinase Melk as Novel E2F Target Genes Down-regulated by 1,25-Dihydroxyvitamin D3 J. Biol. Chem., November 11, 2005; 280(45): 37319 - 37330. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Christensen, P. Cloos, U. Toftegaard, D. Klinkenberg, A. P. Bracken, E. Trinh, M. Heeran, L. Di Stefano, and K. Helin Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription Nucleic Acids Res., September 22, 2005; 33(17): 5458 - 5470. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Balciunaite, A. Spektor, N. H. Lents, H. Cam, H. te Riele, A. Scime, M. A. Rudnicki, R. Young, and B. D. Dynlacht Pocket Protein Complexes Are Recruited to Distinct Targets in Quiescent and Proliferating Cells Mol. Cell. Biol., September 15, 2005; 25(18): 8166 - 8178. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Vandepoele, K. Vlieghe, K. Florquin, L. Hennig, G. T.S. Beemster, W. Gruissem, Y. Van de Peer, D. Inze, and L. De Veylder Genome-Wide Identification of Potential Plant E2F Target Genes Plant Physiology, September 1, 2005; 139(1): 316 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
PREVENT IV Investigators Efficacy and Safety of Edifoligide, an E2F Transcription Factor Decoy, for Prevention of Vein Graft Failure Following Coronary Artery Bypass Graft Surgery: PREVENT IV: A Randomized Controlled Trial JAMA, November 16, 2005; 294(19): 2446 - 2454. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Conti and G. C. Hunter Gene Therapy and Vein Graft Patency in Coronary Artery Bypass Graft Surgery JAMA, November 16, 2005; 294(19): 2495 - 2497. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |